Today: 16 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk raised its offer for Metsera to about $10 billion, topping Pfizer’s $8.1 billion bid. Metsera’s board labeled Novo’s bid “superior,” triggering a two-day window for Pfizer to respond. Pfizer has filed lawsuits in Delaware and federal court to block Novo’s challenge. Shares in Metsera jumped 20% after the news, while Novo’s stock slipped.
4 November 2025
···
Netflix Rumors Send iHeartMedia Stock Soaring – A Deep Dive into IHRT’s 2025 Outlook

Netflix Rumors Send iHeartMedia Stock Soaring – A Deep Dive into IHRT’s 2025 Outlook

iHeartMedia shares surged as much as 30% to a 52-week high of $3.90 on November 4, 2025, after reports that Netflix is in talks to license its video podcasts. The stock traded around $3.40 by mid-day, up over 100% year-to-date but still down 67% over three years. iHeart carries over $5 billion in debt and faces high interest costs. Q3 earnings are due November 10, with analysts expecting a break-even quarter.
4 November 2025
·
Global Payments (GPN) Surges on Earnings Beat and Transformation – What’s Next for This Fintech Powerhouse?

Global Payments (GPN) Surges on Earnings Beat and Transformation – What’s Next for This Fintech Powerhouse?

Global Payments Inc. reported adjusted Q3 2025 earnings of $3.26 per share, up 12% year-over-year and above estimates, with net revenue rising 3% to $2.43 billion. Shares jumped nearly 8% after results but remain down 31% year-to-date. The company is acquiring Worldpay for $24.25 billion and divesting Issuer Solutions for $13.5 billion, with both deals expected to close by Q1 2026.
4 November 2025
···
Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

Dow Falls as Palantir Plunges – Is the AI Stock Boom Turning into a Bubble?

The Dow fell 0.5% Monday as UnitedHealth and Merck dropped, while the Nasdaq rose 0.5% on Amazon’s 4% jump after a $38 billion OpenAI deal. Palantir slid 8% despite beating revenue estimates, dragging other AI stocks lower. Wall Street leaders and Michael Burry warned of an AI-driven bubble and possible correction. Investors showed caution as weak manufacturing data and Fed policy jitters reversed early gains.
4 November 2025
·········
Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz Stock Skyrockets on First Profit in 2 Years – What It Means for Investors

Hertz posted a Q3 2025 net profit of $184 million, its first in nearly two years, compared to a $1.3 billion loss a year ago. Shares jumped up to 27% after earnings beat forecasts, with revenue at $2.5 billion. Fleet upgrades and cost cuts pushed utilization to 84% and slashed depreciation. Hertz scaled back its EV push in 2024, selling 20,000 electric vehicles amid weak rental demand and high costs.
4 November 2025
·
Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Dave Inc. (DAVE) Stock – Fintech Underdog Turned Wall Street Rocket

Dave Inc. stock surged nearly 10% to $264 on November 4 after posting record Q3 revenue of $150.8 million and net income of $92 million. Shares have soared about 500% in the past year, far outpacing the S&P 500. The stock trades near its 52-week high of $286.45, with volatility high and roughly 16% of its float sold short. Most analysts rate DAVE a Buy, with a consensus target of $274.
4 November 2025
·
Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture (SCNX) shares surged 40% to $0.99 pre-market Nov. 4 after its hypertension drug Arbli™ was added to major insurance formularies, expanding coverage to over 100 million people. The company reported just $0.13 million in revenue and a $20 million net loss over the past year. SCNX trades near $0.71, down from a 52-week high of $8.81. Analysts remain cautious, citing high cash burn and uncertain Arbli sales.
4 November 2025
·
Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

Prelude Therapeutics (PRLD) Stock’s Wild Ride: 150% Surge, Big Pharma Deal & What’s Next

Prelude Therapeutics shares surged over 150% on Nov. 3, then dropped about 40% the next day amid record trading. The swings followed news that Incyte Corp. will pay $60 million upfront for rights to Prelude’s JAK2 inhibitor program, with future payments possible. Prelude is pausing one pipeline program, refocusing on two others, and its Chief Medical Officer has departed. Cash reserves now extend operations into 2027.
4 November 2025
··
Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Ondas Holdings (NASDAQ: ONDS) closed at $6.15 on Nov. 3, 2025, after surging above $11 in October and remains up 200% year-to-date. The company announced a deal to acquire Israeli counter-drone firm Sentrycs last week, following several recent defense tech acquisitions. Analysts’ average 1-year price target is $9.50. Shares are in a short-term downtrend, with heavy trading volume and key support near $5.86.
4 November 2025
·
Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Cipher Mining (CIFR) Rockets on AI Mega-Deals & Bitcoin Boom – What Investors Need to Know

Cipher Mining shares surged 24% to $23 after announcing a $5.5 billion AWS data center deal, lifting its market cap to $9 billion. The company reported Q3 revenue of $71.7 million and a net loss of $0.01 per share, beating forecasts. Cipher also secured an $8.5 billion pipeline of AI hosting contracts and remains a leading Bitcoin miner with 23.6 EH/s deployed.
4 November 2025
····
Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kimberly-Clark agreed to acquire Kenvue for $48.7 billion on Nov. 3, 2025, a 46% premium to its prior close. Kenvue shares surged nearly 20% on the news, while Kimberly-Clark stock dropped 13%. The deal follows a turbulent year for Kenvue, including a CEO ouster, falling sales, and litigation over Tylenol safety claims. Kenvue posted $15 billion in 2025 revenue and maintained gross margins near 59%.
4 November 2025
···
Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bitfarms (BITF) 2025 Stock Surge: Bitcoin Miner’s $500M Windfall & AI Pivot Fuel Rally

Bitfarms closed a $588 million convertible notes offering on Oct. 21, 2025, to fund expansion. Shares hit a 52-week high of $5.66 in mid-October, up 197% year-over-year, with a market cap near $2.3 billion. Q2 revenue jumped 87% to $78 million, but the company posted a $29 million net loss. Liquidity stood at $230 million in Q2, with a current ratio of 3.1.
4 November 2025
···
Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

Nvidia’s $5 Trillion Milestone: AI Boom Propels NVDA Stock to New Heights

Nvidia’s market value topped $5 trillion after shares rose nearly 3% to about $206 in late October, making it the world’s most valuable company. Q2 FY2025 revenue hit $46.74 billion, beating estimates, as demand for AI chips drove a 1,000% revenue surge in five years. Nvidia now controls about 80% of the global AI accelerator chip market. It recently announced a $100 billion partnership with OpenAI and a $1 billion investment in Nokia.
4 November 2025
···
Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma (EVOK) Stock Skyrockets on Buyout News – What’s Behind the Surge?

Evoke Pharma shares jumped about 135% to $10.77 on Nov. 4, 2025, after announcing a buyout by QOL Medical for $11 per share in cash. The $17 million deal, approved by both boards, is expected to close by year-end. Evoke’s only product is Gimoti, an FDA-approved nasal spray for diabetic gastroparesis. Q2 net sales rose 47% to $3.8 million, but the company remains unprofitable.
4 November 2025
··
Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis 2025: Animal Health Giant’s Latest Breakthroughs, Stock Outlook & Key Investor Insights

Zoetis reported 2024 revenue of $9.3 billion, up 9% from 2023, with gross margins near 72% and net profit margin around 29%. Shares traded at $130–$135 in November 2025, down from a 52-week high of $180. The company raised its dividend by 15% to $2.00 per share. Analysts’ average 12-month target is $188, though some issued downgrades in late 2025 amid slowing growth.
4 November 2025
··
Harley-Davidson Stock Roars on Earnings Beat – Is HOG a Buy Heading into 2026?

Harley-Davidson Stock Roars on Earnings Beat – Is HOG a Buy Heading into 2026?

Harley-Davidson stock rose nearly 2% to about $27.60 on Nov. 4, 2025, after reporting Q3 earnings far above expectations. Diluted EPS hit $3.10, nearly double forecasts, and revenue climbed 17% to $1.34 billion. Global retail unit sales fell 6% as demand softened, but premium touring models saw strong sales. Analyst views remain mixed, with Morgan Stanley downgrading the stock while others maintain buy ratings.
4 November 2025
··
Yum! Brands Stock on the Rise: Earnings Beat, Pizza Hut Shakeup & 2025 Outlook

Yum! Brands Stock on the Rise: Earnings Beat, Pizza Hut Shakeup & 2025 Outlook

Yum! Brands shares rose over 2% in pre-market trading Nov. 4 after Q3 earnings beat forecasts, with revenue up 8.4% to $1.98 billion and adjusted EPS at $1.58. CEO Chris Turner launched a strategic review of Pizza Hut, which posted its seventh straight sales decline and now accounts for just 11% of operating profit. Yum pays a $0.71 quarterly dividend and continues buybacks. Analysts set average price targets in the low $160s.
4 November 2025
·
Norwegian Cruise Line Stock Plunges Despite Record Quarter – Is NCLH Still Set to Sail High in 2025?

Norwegian Cruise Line Stock Plunges Despite Record Quarter – Is NCLH Still Set to Sail High in 2025?

Norwegian Cruise Line Holdings shares fell about 10% to $20 intraday on Nov. 4 after Q3 revenue missed estimates, despite raising full-year EPS guidance. The stock is down roughly 9% year-to-date, underperforming Carnival. Q3 adjusted EPS beat expectations, but free cash flow was negative due to new ship spending. Market cap stands at $10.1 billion, with heavy debt and no dividend.
4 November 2025
·
ADM Stock Plummets on Outlook Cut – Key Facts and What’s Next

ADM Stock Plummets on Outlook Cut – Key Facts and What’s Next

ADM shares fell about 10% to $54 on Nov. 4 after the company cut its 2025 profit forecast and missed Q3 revenue estimates. Adjusted Q3 earnings were $0.92 per share, above forecasts, but revenue of $20.37 billion missed expectations. The new full-year EPS outlook of $3.25–$3.50 is well below Wall Street estimates. Year-to-date, ADM stock remains up 19%.
4 November 2025
·
1 … 54 55 56 57 58 … 148

Stock Market Today

  • 3 Reasons to Avoid Etsy Stock and a Better Alternative to Consider
    June 16, 2026, 5:27 PM EDT. Etsy's stock price rose 33.2% in six months, outperforming the S&P 500 by 24%, but analysts advise caution. Key concerns include a 1.7% annual decline in active buyers, signaling weak product appeal; sell-side forecasts predicting a 2.3% revenue drop over the next year; and stagnant earnings per share (EPS) growth that trails revenue increases. The stock trades at 12.4 times forward EV/EBITDA, suggesting high expectations already priced in. Investors may find better value in other sectors, particularly software stocks with stronger fundamentals and momentum. Etsy's recent gains appear driven by positive sentiment rather than sustainable business growth.

Latest articles

AAL jumps as oil falls and Jefferies lifts target

AAL jumps as oil falls and Jefferies lifts target

16 June 2026
American Airlines shares rose 1.6% to $15.71 as oil prices plunged 5% on hopes for a Strait of Hormuz reopening, easing fuel cost pressures; Jefferies raised its price target to $15, citing solid demand and higher fares, but warned risks remain if oil rebounds or the strait deal stalls.
Go toTop